Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

por Zheng, Wan-Xiang, Yan, Fei, Xue, Qin, Wu, Guo-Jun, Qin, Wei-Jun, Wang, Fu-Li, Qin, Jun, Tian, Chun-Juan, Yuan, Jian-Lin
Publicado 2015